Gemcitabine-radiotherapy in patients with locally advanced pancreatic cancer.
暂无分享,去创建一个
G. Peters | G. Giaccone | M. Cuesta | B. Slotman | J. Langendijk | H. Pinedo | J. V. van Riel | S. Meijer | C. V. van Groeningen | S. De Lange | O. Meijer
[1] M. Strawderman,et al. Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] D. Gouma,et al. Feasibility and efficacy of high dose conformal radiotherapy for patients with locally advanced pancreatic carcinoma , 2000, Cancer.
[3] Michael R. Green,et al. CALGB Study 9431: A randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy (Ind CT) and concomitant chemoradiotherapy (XRT) for unresectable stage III non-small cell lung cancer (NSCLC) , 2000 .
[4] S. Lele,et al. Prospective audit following the introduction of short‐course preoperative radiotherapy for rectal cancer , 2000, The British journal of surgery.
[5] V. Grégoire,et al. Chemo-radiotherapy: radiosensitizing nucleoside analogues (review). , 1999, Oncology reports.
[6] J. Tepper,et al. Phase I trial of twice-weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] D. V. Von Hoff,et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] A. Gregor. Gemcitabine plus radiotherapy for non-small cell lung cancer. , 1997, Seminars in oncology.
[9] G. Soete,et al. Intrinsic radiosensitivity of human pancreatic tumour cells and the radiosensitising potency of the nitric oxide donor sodium nitroprusside. , 1996, British Journal of Cancer.
[10] T. Lawrence,et al. Radiosensitization of human solid tumor cell lines with gemcitabine. , 1996, Seminars in oncology.
[11] P. Thomas. Radiotherapy for carcinoma of the pancreas. , 1996, Seminars in oncology.
[12] T. Lawrence,et al. Metabolism of 2',2'-difluoro-2'-deoxycytidine and radiation sensitization of human colon carcinoma cells. , 1994, Cancer research.
[13] Birgir Gudjonsson,et al. Cancer of the pancreas: 50 years of surgery , 1987, Cancer.
[14] J. Barkin,et al. Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5‐fluorouracil), and high dose radiation + 5‐fluorouracil. The gastrointestinal tumor study group , 1981, Cancer.
[15] K. Brace,et al. Aorto-duodenal fistula following abdominal irradiation for Hodgkin's disease. A case report. , 1972, Journal of the Canadian Association of Radiologists.
[16] E. Casper,et al. Phase II trial of gemcitabine (2,2′-difiuorodeoxycytidine) in patients with adenocarcinoma of the pancreas , 2004, Investigational New Drugs.
[17] J. Vauthey,et al. Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer , 2001, International journal of gastrointestinal cancer.
[18] H. Wanebo,et al. Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer. , 2000, Archives of surgery.
[19] A. Kuten,et al. A phase II study of gemcitabine combined with radiation therapy in patients with localized unresectable pancreatic cancer , 2000 .
[20] K. Ang,et al. Enhancement of tumor radioresponse in vivo by gemcitabine. , 1999, Cancer research.
[21] G. Giaccone,et al. Current chemotherapeutic possibilities in pancreaticobiliary cancer. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.
[22] K. Ang,et al. Maximizing therapeutic gain with gemcitabine and fractionated radiation. , 1999, International journal of radiation oncology, biology, physics.
[23] C. V. Groeningen. Intravenous and intra-arterial chemotherapeutic possibilities in biliopancreatic cancer , 1999 .
[24] M. Anscher,et al. Preoperative Chemoradiation for Patients With Locally Advanced Adenocarcinoma of the Pancreas , 1999, Annals of Surgical Oncology.
[25] P. Wingo,et al. Cancer statistics, 1996 , 1996, CA: a cancer journal for clinicians.
[26] A. Miller,et al. Reporting results of cancer treatment , 1981, Cancer.
[27] R. D. Hunter,et al. WHO Handbook for Reporting Results of Cancer Treatment , 1980 .